Avego News Stay informed with the latest updates from Avego and our portfolio. Next section June 6 2024 ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences Read more June 6 2023 AtomVie Global Radiopharma raises over $90M to Complete its New Facility Buildout Read more March 3 2023 Alimera Improves Capital Structure, Strengthens Balance Sheet and Extends Term Loan Facility Read more January 1 2023 PBS Biotech Raises $22M to Expand Single-Use Manufacturing Products and Services for Cell Therapy Clients Read more November 11 2022 Escient Pharmaceuticals Announces $120 Million Series C Financing Read more August 8 2022 AtomVie Global Radiopharma Inc. Announces its Spinout and Series A Financing with Avego Read more January 1 2022 Amneal Acquires Saol Therapeutics’ Baclofen Franchise Read more December 12 2021 Saol Therapeutics Announces FDA Approval of LYVISPAH™ (baclofen) Oral Granules and the Divesture of its Plasma-derived Hyperimmune Portfolio Read more November 11 2021 Ellie Diagnostics Raises Growth Equity from Avego Healthcare Capital Read more November 11 2021 Antios Therapeutics Raises $75 Million in a Series B-1 Funding to Advance Clinical Programs for HBV Read more October 10 2021 Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition Corporation Read more August 8 2021 Ribon Therapeutics Secures $65 Million Financing Read more Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Merger to Create a Publicly Listed Leading Biotechnology Company in Hematopoietic Stem Cell Transplantation Read more Arch Oncology Secures $105 Million Series C Financing Read more Caribou Biosciences Raises $115M Series C Financing to Advance Next-Generation CRISPR Technologies and Allogeneic Cell Therapy Pipeline Read more Santen and U.S. Ophthalmic Company Eyevance Enter into Share Purchase Agreement Read more